Jump to Content

advertising

Logo Logo Logo Logo Logo Logo
Browse
About Editorial Board Get Permission
Current Issue Future Issues
Online Early Author Center Reviewers
Members Individuals Institutions FAQs
Advertising
Advanced Search Help
Logo Logo Logo Logo Logo Logo
Sign in Sign up Contact Help
Browse
About Editorial Board Get Permission
Current Issue Previous Issues
Online Early Author Center Reviewers
Members Individuals Institutions FAQs
Advertising
Advanced Search Help
Cover Journal of the American Podiatric Medical Association
Journal of the American Podiatric Medical Association
ISSN:
8750-7315

We Need You! Join the JAPMA Peer Review Team

  • Previous Issue
  • Next Issue

Volume 92 (2002): Issue 3 (Mar 2002)

Publication Date:
01 Mar 2002
Get eTOC Alerts Get Ahead of Print Alerts
ORIGINAL ARTICLES
Symptomatic Reversal of Peripheral Neuropathy in Patients with Diabetes
The Mozena Classification System and Treatment Algorithm for Ingrown Hallux Nails
Clinical and Dynamic Range-of-Motion Techniques in Subjects With and Without Diabetes Mellitus
A Comparative Study of Lactic Acid 10% and Ammonium Lactate 12% Lotion in the Treatment of Foot Xerosis
CLINICALLY SPEAKING
Pedal Gangrene Secondary to Disseminated Intravascular Coagulation with Gastric Carcinoma
Congenital Absence of the Tibial Sesamoid
Capillary Hemangioma of the Foot
RESEARCH AND PRACTICE
Introduction
‘Horses for Courses’: The Differences Between Quantitative and Qualitative Approaches to Research
REGULAR FEATURE
Council on Podiatric Medical Education: Eighty-Second Annual Report, 2001
PRESIDENT’S MESSAGE
The Strength of Podiatric Medicine
Additional Content
Table of Contents
Email this content

Share Link


Copy this link, or click below to email it to a friend
Email this content
or copy the link directly:
The link was not copied. Your current browser may not support copying via this button.
Link copied successfully

advertising

JAPMA Home

About Issues Submit a Manuscript Peer Review
Advertising Proprietary Rights Notice Privacy Policy

Connect with us:

Powered by PubFactory
  • [18.97.14.82]
  • 18.97.14.82
Close
Edit

Character limit 500/500

@!

Character limit 500/500